Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 25: The CORALreef HeFH Trial
Author(s): Christie Ballantyne Added: 2 days ago
AHA Scientific Sessions 2025 - Dr Christie Ballantyne (Baylor College of Medicine, Houston, TX, US) discusses findings from the CORALreef HeFH trial, examining the efficacy and safety of enlicitide decanoate, an oral PCSK9 inhibitor, in adults with heterozygous familial hypercholesterolemia.This Phase 3, randomized, double-blind, placebo-controlled study evaluated 303 participants with… View more

Cardiovascular Renal Metabolic
ESC 23: LIBerate-HeFH Study
Author(s): Frederick Raal Added: 2 years ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104). The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in… View more

Inherited and Congenital Cardiac Conditions

Prevention & Chronic Conditions
AHA 24: The LIBerate-HeFH_OLE Study
Author(s): Frederick Raal Added: 11 months ago
AHA Conference 2024 - Long-term safety and efficacy outcomes of lerodalcibep, a third generation PCSK9 inhibitor (LIB Therapeutics LLC), in heterozygous familial hypercholesterolemia (HoFH) subjects.Prof Frederick Raal (University of the Witwatersrand, ZA) joins us onsite at AHA Conference to discuss the findings from LIBerate-HeFH_OLE (NCT04798430; LIB Therapeutics).LIBerate-HeFH_OLE is an open… View more

Prevention & Chronic Conditions
Job title: Associate Adjunct Professor in Cardiology
Dr Payal Kohli is an Associate Adjunct Professor in Cardiology Division, Department of Medicine at Duke University and at Johns Hopkins University, US. Dr Kohli earned her undergraduate degree from Massachusetts Institute of Technology (MIT) with a perfect GPA and her medical degree from Harvard Medical School, magna cum laude. She is Board-certified in Internal Medicine, Cardiology and… View more
Author(s): Evan A Stein Added: 1 year ago
ACC.24 — We are joined onsite by investigator, Dr Evan A Stein (Medpace Reference Laboratories, US) to discuss the findings from the LIBerate-CVD trial (NCT04797247).LIBerate-CVD investigated LDL-C reductions in a cohort of 900 patients with cardiovascular diseases and hyper-LDL-cholesterol treated with 300mg subcutaneous Lerodalcibep as compared to placebo across a 52-week treatment period… View more

Prevention & Chronic Conditions
Kausik Ray
Research Area(s) / Expertise: Job title: Professor of Public Health
Professor Kausik Ray is currently Professor of Public Health, Deputy Director of Imperial Clinical Trials Unit and Head of Commercial Trials within the Department of Public Health and Primary Care, School of Public Health, Imperial College London, Consultant Cardiologist and Chief Clinical Officer and Head of Trials – Discover Now as well as NIHR ARC National Lead of Cardiovascular Disease.Prof… View more
Links between NAFLD/NASH and Cardiometabolic Syndrome
Author(s): Sheila Gato , Vanessa García-Fernández , Antonio Gil-Gómez , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Michael D Shapiro
Research Area(s) / Expertise: Job title: Director of the Center for Preventive Cardiology
Personal History Dr Shapiro lives in Winston-Salem with his wife and their two children. In his spare time, he enjoys travelling and hiking. Academic History Dr Shapiro completed medical school in 1998 at the UMDNJ School of Osteopathic Medicine. After completing a cardiology fellowship at the Beth Israel Medical Center, he spent two additional years in a clinical and research… View more
Atorvastatin and Ezetimibe in Patients with Acute Coronary Syndrome
Author(s): Mohammed Sallam , Hossameldin Hassan , Derek Connolly , et al Added: 12 months ago

Prevention & Chronic Conditions

MI/ACS
Meta-analysis and Meta-regression Applicability
Author(s): Alberto Cordero , Carlos G Santos-Gallego , Armando Oterino , et al Added: 1 month ago

CV Disease in Special Populations